
Journal of Medicinal Chemistry p. 425 - 432 (1993)
Update date:2022-09-26
Topics:
Burke Jr.
Lim
Marquez
Li
Bolen
Stefanova
Horak
A study was undertaken to prepare inhibitors of the lymphocyte protein- tyrosine kinase p56(lck). Using the known p56(lck) inhibitor 3,4-dihydroxy- α-cyanocinnamamide (4) as a lead compound, bicyclic analogues were designed as conformationally constrained
View MoreContact:852-27701081
Address:Room 2509, New Tech Plaza, 34 Tai Yau St., San Po Kong, HK
website:http://www.chinabarton.com
Contact:+86-573-82719618
Address:No. 162 Fumin Road, Honghe Town,
Shanghai HengXun Pharmaceutical Tech. Co., Ltd.
Contact:86-86-52730756
Address:Room 603, No. 240, Tianmuzhong Road, Zhabei, Shanghai, China
China Synchem Technology Co.,Ltd
website:http://www.cnsynchem.com
Contact:+86-0552-4929311
Address:No.217 Daqing Road
Hangzhou yi lu biont technology Co., LTD
Contact:+86-571-88152630
Address:Hangzhoushi HuafengRoad Yicheng3Building1001room.
Doi:10.1021/ol202751s
(2011)Doi:10.1007/s00044-011-9857-0
(2012)Doi:10.1021/jm00080a028
(1992)Doi:10.1055/s-1991-26464
(1991)Doi:10.1021/jo00016a001
(1991)Doi:10.1021/ja01486a058
(1960)